News and media

Laura Birks | 19/03/2021

The March 2021 edition of MND Australia's International Research Update is now available. 

Laura Birks | 16/03/2021

MND Research Australia has awarded 2021-23 PhD top-up scholarships to two outstanding early career researchers: Anna Ridgers from Austin Health and Natalie Grima from Macquarie University. PhD top up grants encourage promising early career researchers to focus their talents on developing cures, treatments and better models of care for people living with motor neurone disease. This year, we are delighted to award these in the areas of genomics (Natalie Grima) and care research (Anna Ridgers).

Morag Millington | 2/03/2021

MEDIA RELEASE

MND Australia strongly welcomes the recommendations from the Aged Care Royal Commission Final Report which would enormously improve the care and support that older Australians with a disability, like motor neurone disease, currently receive under the Aged Care system.

Morag Millington | 9/02/2021

The MND Australia Conference focuses on improving care and support for people living with MND.

Morag Millington | 25/11/2020

The Board of MND Australia is delighted to announce the appointment of David Ali as its new Chief Executive Officer.

Morag Millington | 24/11/2020

We are pleased to announce that our research arm, MND Research Australia, has awarded close to $3 million in grants for MND research commencing in 2021.

Morag Millington | 3/11/2020

MEDIA RELEASE

Morag Millington | 30/10/2020

We were delighted to learn this week that an early feasibility study of the Stentrode brain implant has successfully shown that it can aid people living with paralysis, such as those with MND, to continue to maintain communication. MND Research Australia funded early research into development of this device. 

Morag Millington | 13/10/2020

While MND Australia welcomes the much needed investments in aged care, health, disability & research handed down in the Budget, we believe that significant further funding is still required in these sectors. 

Carol Birks | 8/10/2020

A recent publication by MNDRA-funded Melbourne researchers has identified an immune pathway that may play a key role in the neuroinflammation seen in MND and present a novel target for developing new treatments.

They found that by blocking an immune sensor called STING, they could dramatically prevent inflammation from MND patient cells, paving the way for a new class of drugs to be developed for people with neurodegenerative disorders, such as MND.